Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Business Model:
Revenue: $6.8M
Employees: 11-50
Address: 1 Broadway Fl 14
City: Cambridge
State: MA
Zip: 02142
Country: US
Remiges is a venture capital firm specializing in early stage investments in biotechnology, life science, and startups.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2022 | Immunis | Series A | 0 |
12/2020 | Cyrano Therapeutics | Series A | 12.8M |
11/2018 | OMEICOS Therapeutics | Series C | 0 |
6/2018 | KisoJi Biotechnology | Series A | - |
6/2017 | Mitoconix Bio | Series A | 20M |
9/2018 | ENB Therapeutics | Series A | 8.1M |
6/2021 | Glycomine | Series B | 0 |
9/2020 | LUCA Science | Series A | 0 |
6/2016 | InFlectis BioScience | Series A | 6.8M |
2/2022 | Restore Vision | Seed Round | 2.6M |
10/2017 | OMEICOS Therapeutics | Series B | - |
6/2022 | LUCA Science | Series B | 29.2M |
9/2022 | Kupando | Series A | 0 |
7/2020 | Tranquis Therapeutics | Series A | 30M |
8/2022 | Immunis | Series A | 0 |
6/2022 | LUCA Science | Series B | 0 |
2/2022 | Restore Vision | Seed Round | 0 |
6/2021 | Glycomine | Series B | 0 |
12/2020 | Cyrano Therapeutics | Series A | 0 |
9/2020 | LUCA Science | Series A | 0 |
7/2020 | Tranquis Therapeutics | Series A | 0 |
11/2018 | OMEICOS Therapeutics | Series C | 0 |
9/2018 | ENB Therapeutics | Series A | 0 |
6/2018 | KisoJi Biotechnology | Series A | - |
Name | Price |
---|
Name | Size | Announced Date |
---|